Baloda V - Search Results

1

COVID-19 mRNA Vaccines May Cause False Reactivity in Some Serologic Laboratory Tests, Including Rapid Plasma Reagin Tests.

Korentzelos D, Baloda V, Jung Y, Wheeler B, Shurin MR, Wheeler SE. Korentzelos D, et al. Among authors: baloda v. Am J Clin Pathol. 2022 Aug 4;158(2):162-166. doi: 10.1093/ajcp/aqac025. Am J Clin Pathol. 2022. PMID: 35353142 Free PMC article.

2

Pilot Verification of a Novel Approach to Remove Electrophoretic Interference of the Therapeutic Monoclonal Antibody Daratumumab.

Baloda V, Shurin MR, Wheeler SE. Baloda V, et al. J Appl Lab Med. 2022 Jun 30;7(4):910-915. doi: 10.1093/jalm/jfab174. J Appl Lab Med. 2022. PMID: 35060610 Free article.

3

Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.

Baloda V, Wheeler SE, Murray DL, Kohlhagen MC, Vos JA, Yatsenko SA, Agha ME, Djokic M, Swerdlow SH, Bailey NG. Baloda V, et al. Diagn Pathol. 2022 Aug 5;17(1):63. doi: 10.1186/s13000-022-01244-1. Diagn Pathol. 2022. PMID: 35932039 Free PMC article. Review.

4

Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid Testing.

Peck Palmer O, Hasskamp JH, La HS, Pramod Patwardhan P, Ghumman S, Baloda V, Jung Y, Wheeler SE. Peck Palmer O, et al. Among authors: baloda v. Lab Med. 2023 Mar 7;54(2):e54-e57. doi: 10.1093/labmed/lmac107. Lab Med. 2023. PMID: 36065160 Free PMC article.

5

Correction: Mu heavy chain disease with MYD88 L265P mutation: An unusual manifestation of lymphoplasmacytic lymphoma.

Baloda V, Wheeler SE, Murray DL, Kohlhagen MC, Vos JA, Yatsenko SA, Agha ME, Djokic M, Swerdlow SH, Bailey NG. Baloda V, et al. Diagn Pathol. 2022 Oct 20;17(1):84. doi: 10.1186/s13000-022-01265-w. Diagn Pathol. 2022. PMID: 36266677 Free PMC article. No abstract available.

6

Tixagevimab Plus Cilgavimab Does Not Affect the Interpretation of Electrophoretic and Free Light Chain Assays.

Baloda V, McCreary EK, Goscicki BK, Shurin MR, Wheeler SE. Baloda V, et al. Am J Clin Pathol. 2023 Jan 4;159(1):10-13. doi: 10.1093/ajcp/aqac137. Am J Clin Pathol. 2023. PMID: 36469049

7

Use of smooth muscle markers is better than the endothelial cell markers for identification of tumor venous invasion and extramural tumor deposits in gastrointestinal tract tumors.

Das P, Baloda V. Das P, et al. Among authors: baloda v. Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):3-4. doi: 10.4103/IJPM.IJPM_284_19. Indian J Pathol Microbiol. 2020. PMID: 32031113 No abstract available.

8

SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.

Khetan K, Baloda V, Sahoo RK, Vishnubhathla S, Yadav R, Saraya A, Sharma A, Gupta SD, Das P. Khetan K, et al. Among authors: baloda v. Pathol Res Pract. 2019 Dec;215(12):152685. doi: 10.1016/j.prp.2019.152685. Epub 2019 Oct 21. Pathol Res Pract. 2019. PMID: 31727501

9

Histological assessment & use of immunohistochemical markers for detection of dysplasia in Barrett's esophageal mucosa.

Kinra P, Gahlot GPS, Yadav R, Baloda V, Makharia GK, Gupta SD, Das P. Kinra P, et al. Among authors: baloda v. Pathol Res Pract. 2018 Jul;214(7):993-999. doi: 10.1016/j.prp.2018.05.006. Epub 2018 May 16. Pathol Res Pract. 2018. PMID: 29764708

10

Histologic Changes in Core-Needle Liver Biopsies From Patients With Acute-on-Chronic Liver Failure and Independent Histologic Predictors of 28-Day Mortality.

Baloda V, Anand A, Yadav R, Mehra L, Rajeshwari M, Vishnubhatla S, Upadhyay AD, Dwivedi SN, Nayak B, Saraya A, Acharya SK, Datta Gupta S, Shalimar, Das P. Baloda V, et al. Arch Pathol Lab Med. 2022 Jul 1;146(7):846-854. doi: 10.5858/arpa.2021-0103-OA. Arch Pathol Lab Med. 2022. PMID: 34705032 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page